iohexol has been researched along with Cardiomyopathy, Hypertrophic in 5 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diffuse fibrosis was poorly visualized by ceMDCT but was detectable using quantitative measurements." | 1.39 | Cardiac computed tomographic imaging to evaluate myocardial scarring/fibrosis in patients with hypertrophic cardiomyopathy: a comparison with cardiac magnetic resonance imaging. ( Berliner, JI; Bonow, RO; Carr, JC; Choudhury, L; Kino, A, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, W | 1 |
| Huang, H | 1 |
| Jiang, B | 1 |
| Liu, ZY | 1 |
| He, Y | 1 |
| Langer, C | 1 |
| Lutz, M | 1 |
| Eden, M | 1 |
| Lüdde, M | 1 |
| Hohnhorst, M | 1 |
| Gierloff, C | 1 |
| Both, M | 1 |
| Burchert, W | 1 |
| Faber, L | 1 |
| Horstkotte, D | 1 |
| Frey, N | 1 |
| Prinz, C | 1 |
| Zhao, L | 1 |
| Ma, X | 1 |
| Feuchtner, GM | 1 |
| Zhang, C | 1 |
| Fan, Z | 1 |
| Nagaraj, U | 1 |
| King, M | 1 |
| Shah, S | 1 |
| Ghosh, S | 1 |
| Berliner, JI | 1 |
| Kino, A | 1 |
| Carr, JC | 1 |
| Bonow, RO | 1 |
| Choudhury, L | 1 |
1 review available for iohexol and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
[Iopromide-Induced Encephalopathy: A Case Report and Literature Review].
Topics: Adult; Brain Diseases; Cardiomyopathy, Hypertrophic; Coronary Angiography; Humans; Iohexol; Male | 2021 |
4 other studies available for iohexol and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Hypertrophic cardiomyopathy in cardiac CT: a validation study on the detection of intramyocardial fibrosis in consecutive patients.
Topics: Cardiomyopathy, Hypertrophic; Contrast Media; Female; Fibrosis; Heart; Humans; Iohexol; Male; Middle | 2014 |
Quantification of myocardial delayed enhancement and wall thickness in hypertrophic cardiomyopathy: multidetector computed tomography versus magnetic resonance imaging.
Topics: Cardiac-Gated Imaging Techniques; Cardiomyopathy, Hypertrophic; Contrast Media; Coronary Angiography | 2014 |
Evaluation of discrete upper septal thickening on 64-slice coronary computed tomographic angiography.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Blood Pressure; Cardiomyopathy, Hypert | 2012 |
Cardiac computed tomographic imaging to evaluate myocardial scarring/fibrosis in patients with hypertrophic cardiomyopathy: a comparison with cardiac magnetic resonance imaging.
Topics: Adult; Analysis of Variance; Cardiomyopathy, Hypertrophic; Cicatrix; Contrast Media; Female; Fibrosi | 2013 |